The present invention is directed to pharmaceutical compositions containing 2-carboxylic indole derivatives. The compounds are excitatory amino acid antagonists.
PROBENECID FOR USE IN TREATING EPILEPTIC DISEASES, DISORDERS OR CONDITIONS
申请人:PARIS SCIENCES ET LETTRES - QUARTIER LATIN
公开号:US20200163916A1
公开(公告)日:2020-05-28
Probenecid or a pharmaceutical acceptable salt thereof for use in the treatment of a neurological disorder in a subject in need thereof, wherein administration of probenecid or a pharmaceutical acceptable salt thereof controls clinical or electrographic seizures in the subject. Preferably, the neurological disorder is an epileptic disease, disorder or condition.